Accordingly, we propose that the payment limit for a DCAPS drug be determined using the methodology described in section 1847A of the Act (also referred to as ASP methodology), or, if ASP data is not available for a particular drug, to use an alternative pricing mechanism, as described below
Our findings highlight the need for education and supervision to unfold the potential of a personalized, data-driven treatment approach using the OBT
(2) model 1 plus race/ethnicity, educational attainment, marital status, family income, region, and survey years
Q3 2007 earnings call transcript
Cotinine is detectable in blood for at least several days after exposure to tobacco smoke